Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Shuo Liu
WHO Collaborating Center for Standardization and Evaluation of Biologicals
China
Learn more about SSRN Profiles
SCHOLARLY PAPERS
2
DOWNLOADS
91
TOTAL CITATIONS
9
Feedback
Scholarly Papers (2)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
The Impact of Natural and Glycosylation Mutations in the SARS-CoV-2 Spike Protein on Viral Infectivity and Antigenicity
Number of pages: 36
Posted: 14 Jul 2020
Qianqian Li
,
Jiajing Wu
,
Jianhui Nie
,
Li Zhang
,
Huan Hao
, Shuo Liu,
Chenyan Zhao
,
Qi Zhang
,
Huan Liu
,
Lingling Nie
,
Haiyang Qin
,
Meng Wang
,
Qiong Lu
,
Xiaoyu Li
,
Qiyu Sun
,
Junkai Liu
,
Linqi Zhang
,
Xuguang Li
,
Weijin Huang
and
Youchun Wang
WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, Tsinghua University - Center for Global Health and Infectious Diseases, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, Tsinghua University - Center for Global Health and Infectious Diseases, WHO Collaborating Center for Standardization and Evaluation of Biologicals, Government of the People's Republic of China - Division of HIV/AIDS and Sex-transmitted Virus Vaccines and WHO Collaborating Center for Standardization and Evaluation of Biologicals
Downloads
53
(830,013)
Citation
9
View PDF
Download
Abstract:
SARS-CoV-2, COVID-19, mutation, glycosylation, neutralizing antibody, immune escape
2.
No Higher Infectivity But Immune Escape of SARS-CoV-2 501Y.V2 Variants
Number of pages: 37
Posted: 29 Jan 2021
Qianqian Li
,
Jianhui Nie
,
Jiajing Wu
,
Li Zhang
,
Ruxia Ding
,
Haixin Wang
,
Yue Zhang
,
Tao Li
, Shuo Liu,
Mengyi Zhang
,
Chenyan Zhao
,
Huan Liu
,
Lingling Nie
,
Haiyang Qin
,
Meng Wang
,
Qiong Lu
,
Xiaoyu Li
,
Junkai Liu
,
Haoyu Liang
,
Yi Shi
,
Yuelei Shen
,
Liangzhi Xie
,
Linqi Zhang
,
Xiaowang Qu
,
Wenbo Xu
,
Weijin Huang
and
Youchun Wang
WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, National Institutes for Food and Drug Control (NIFDC) - Division of HIV/AIDS and Sex-transmitted Virus Vaccines, National Institutes for Food and Drug Control (NIFDC) - Division of HIV/AIDS and Sex-transmitted Virus Vaccines, National Institutes for Food and Drug Control (NIFDC) - Division of HIV/AIDS and Sex-transmitted Virus Vaccines, National Institutes for Food and Drug Control (NIFDC) - Division of HIV/AIDS and Sex-transmitted Virus Vaccines, WHO Collaborating Center for Standardization and Evaluation of Biologicals, National Institutes for Food and Drug Control (NIFDC) - Division of HIV/AIDS and Sex-transmitted Virus Vaccines, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, WHO Collaborating Center for Standardization and Evaluation of Biologicals, National Institutes for Food and Drug Control (NIFDC) - Division of HIV/AIDS and Sex-transmitted Virus Vaccines, Chinese Academy of Sciences (CAS) - CAS Key Laboratory of Pathogenic Microbiology and Immunology, Beijing Biocytogen Co., Ltd., Sino Biological Inc. - Beijing Antibody Research Key Laboratory, Tsinghua University - Center for Global Health and Infectious Diseases, University of South China - Translational Medicine Institute, Chinese Center for Disease Control and Prevention (China CDC) - National Institute for Viral Disease Control and Prevention, Government of the People's Republic of China - Division of HIV/AIDS and Sex-transmitted Virus Vaccines and WHO Collaborating Center for Standardization and Evaluation of Biologicals
Downloads
38
(961,035)
View PDF
Download
Abstract:
Feedback